Trial Profile
A double-blind placebo-controlled trial of Rozerem [ramelteon] in migraine headaches.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 09 Feb 2012 Actual patient number is 4 according to ClinicalTrials.gov.
- 09 Feb 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 22 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.